Accent Therapeutics
Lexington
About Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology encompasses post-transcriptional chemical modifications of RNA that provide cells with a unique mechanism for regulating proteins critical for cellular growth and differentiation. By targeting cancer-linked RNA-modifying proteins (RMPs) with precision therapies, they aim to translate extraordinary science into life-changing therapies for patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $178.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Jan 2024)
- Website: accenttx.com
- Phone: (339) 970-7400
Industries & Categories
Biotechnology, Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/accent-therapeutics-13363 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.